(c) 2020 PillSync.com

Bumetanide 1 MG Oral Tablet

INDICATIONS AND USAGE Bumetanide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. Almost equal diuretic response occurs after oral and parenteral administration of bumetanide. Therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. Successful treatment with bumetanide tablets following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity.

heritage pharma labs, inc


COVID-19 Cases Near You

Bitcoin Booming in Financial Crisis

Lowest Fees to Trade Crypto

Go PRO to remove this ad
1 month ago ROUND YELLOW 701 Bumetanide 1 MG Oral Tablet

ROUND YELLOW 701

1 month ago ROUND YELLOW 701 Bumetanide 1 MG Oral Tablet

701 ROUND YELLOW

Related Pills

ertugliflozin 5 MG Oral Tablet Steglatro

Merck Sharp & Dohme Corp.

levocetirizine dihydrochloride 5 MG Oral Tablet

Teva Pharmaceuticals USA, Inc.












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site